Article info

Download PDFPDF

Original research
Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung

Authors

  1. Correspondence to Dr Giuseppe Giaccone; gig4001{at}med.cornell.edu
View Full Text

Citation

Kim C, Liu SV, Subramaniam DS, et al
Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung

Publication history

  • Accepted June 2, 2020
  • First published July 2, 2020.
Online issue publication 
July 02, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.